AbbVie Inc. Logo

AbbVie Inc. (ABBV34)

Bovespa

Currency in BRL
85.00
-0.32 (-0.38%)

Closed

Aug 24, 2026

Day's Range

84.72
85.23

52 wk Range

58.81
86.95

Overview - ABBV34 - AbbVie Inc.

Key Statistics

Valuation

Enterprise Value

1.10T

P/E (Trailing)

‪74.19‬

PEG Ratio

‪0.26‬

Price / Sales (TTM)

‪37.46‬

Price / Book

‪-408.60‬

EV / EBITDA

‪6.99‬

Profitability

Gross Margin

‪74.74%‬

Profit Margin

‪9.80%‬

Operating Margin

‪40.03%‬

Return on Assets

‪10.51%‬

Return on Equity

‪-129.67%‬

Ownership

Shares Outstanding

1.76B

Float

1.76B

Held by Insiders

‪0.00%‬

Held by Institutions

‪0.0020%‬

Price stats

Beta

‪0.28‬

50-Day Avg

‪79.74‬

200-Day Avg

‪73.68‬

Dividends

Payout Ratio

‪132.05%‬

Frequency

Quarterly

Peers - ABBV34 - AbbVie Inc.

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on Bovespa.

Profile Summary - ABBV34 - AbbVie Inc.

About

AbbVie Inc. is a prominent biopharmaceutical company dedicated to the research, development, and distribution of innovative medicines and treatments globally. Established in 2013 as a spin-off from Abbott Laboratories, AbbVie focuses on addressing complex and serious health conditions, with core areas of expertise in…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees57K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.